@article{ART003128440,
author={Dorothy Cheuk-Yan Yiu and Huapeng Lin and Vincent Wai-Sun Wong and Grace Lai-Hung Wong and Ken Liu and Terry Cheuk-Fung Yip},
title={Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”},
journal={Clinical and Molecular Hepatology},
issn={2287-2728},
year={2024},
volume={30},
number={4},
pages={970-973}
}

TY - JOUR
AU - Dorothy Cheuk-Yan Yiu
AU - Huapeng Lin
AU - Vincent Wai-Sun Wong
AU - Grace Lai-Hung Wong
AU - Ken Liu
AU - Terry Cheuk-Fung Yip
TI - Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”
T2 - Clinical and Molecular Hepatology
JO - Clinical and Molecular Hepatology
PY - 2024
VL - 30
IS - 4
PB - 대한간학회
SP - 970
EP - 973
SN - 2287-2728
AB -
KW - DPP4i, Liver cancer, Mortality, Systemic therapy
DO -
UR -
ER -

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu and Terry Cheuk-Fung Yip. 2024, "Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”", Clinical and Molecular Hepatology, vol.30, no.4 pp.970-973.

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip "Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”" Clinical and Molecular Hepatology 30.4 pp.970-973 (2024) : 970.

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip. Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”. 2024; 30(4), 970-973.

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu and Terry Cheuk-Fung Yip. "Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”" Clinical and Molecular Hepatology 30, no.4 (2024) : 970-973.

Dorothy Cheuk-Yan Yiu; Huapeng Lin; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Ken Liu; Terry Cheuk-Fung Yip. Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”. Clinical and Molecular Hepatology, 30(4), 970-973.

Dorothy Cheuk-Yan Yiu; Huapeng Lin; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Ken Liu; Terry Cheuk-Fung Yip. Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”. Clinical and Molecular Hepatology. 2024; 30(4) 970-973.

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip. Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”. 2024; 30(4), 970-973.

Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu and Terry Cheuk-Fung Yip. "Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”" Clinical and Molecular Hepatology 30, no.4 (2024) : 970-973.